Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO1 | P15559 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | NQO2 | P16083 | 2/20 | 0.32 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | RPS6KB2 | Q9UBS0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16547258 | 0.86 | KDM4E (0.42) | NQO1KDM4EMAPTNQO2RPS6KB2 | |
| SCHEMBL15581110 | 0.83 | TDP1 (0.42) | NQO1KDM4EMAPTNQO2CYP2C19 | |
| SCHEMBL10846210 | 0.81 | KDM4E (0.38) | NQO1KDM4EMAPTCYP2C19 | |
| SCHEMBL9979793 | 0.81 | NQO1 (0.36) | NQO1KDM4EMAPTNQO2CYP2C19 | |
| 2,3-Dihydroxy-6,7-Dichloroquinoxaline SCHEMBL1259521 | 0.81 | MMP1 (0.50) | NQO2 | |
| SCHEMBL10348834 | 0.81 | MAPT (0.52) | NQO1KDM4EMAPT | |
| SCHEMBL4705252 | 0.81 | PIK3R1 (0.39) | NQO1KDM4EMAPTNQO2 | |
| SCHEMBL1259502 | 0.81 | KDM4E (0.64) | KDM4EMAPTNQO2BACE1 | |
| SCHEMBL18397673 | 0.78 | NQO2 (0.62) | KDM4EMAPTNQO2RPS6KB2 | |
| Hydrochloric Acid SCHEMBL9796912 | 0.78 | KDM4E (0.32) | KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021156605-A1 | PHOTOACTIVE MATERIAL | SUMITOMO CHEMICAL CO., LTD (JP) | 2021-08-12 | — | — | WO | disclosed |
| US-9978474-B2 | Conductive open frameworks | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-05-22 | — | — | US | disclosed |
| US-20160247593-A1 | CONDUCTIVE OPEN FRAMEWORKS | UNITED STATES DEPARTMENT OF ENERGY | 2016-08-25 | — | — | US | disclosed |
| US-9269473-B2 | Conductive open frameworks | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-02-23 | — | — | US | disclosed |
| US-20150065596-A1 | Synthesis of a Highly Crystalline, Covalently Linked Porous Network | UNIVERSITY OF SOUTH CAROLINA | 2015-03-05 | — | — | US | disclosed |
| US-20150065596-A1 | Synthesis of a Highly Crystalline, Covalently Linked Porous Network | UNIVERSITY OF SOUTH CAROLINA | 2015-03-05 | — | — | US | disclosed |
| US-8829065-B2 | Synthesis of a highly crystalline, covalently linked porous network | UNIVERSITY OF SOUTH CAROLINA (US) | 2014-09-09 | — | — | US | disclosed |
| US-20130030072-A1 | Synthesis of a Highly Crystalline, Covalently Linked Porous Network | UNIVERSITY OF SOUTH CAROLINA (US) | 2013-01-31 | — | — | US | disclosed |
| US-8258197-B2 | Synthesis of a highly crystalline, covalently linked porous network | UNIVERSITY OF SOUTH CAROLINA (US) | 2012-09-04 | — | — | US | disclosed |
| US-8258197-B2 | Synthesis of a highly crystalline, covalently linked porous network | UNIVERSITY OF SOUTH CAROLINA (US) | 2012-09-04 | — | — | US | disclosed |
| WO-2012082213-A2 | CONDUCTIVE OPEN FRAMEWORKS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-06-21 | — | — | WO | disclosed |
| US-20090227697-A1 | SYNTHESIS OF A HIGHLY CRYSTALLINE, COVALENTLY LINKED POROUS NETWORK | NATIONAL SCIENCE FOUNDATION | 2009-09-10 | — | — | US | disclosed |
| WO-2007098263-A2 | SYNTHESIS OF A HIGHLY CRYSTALLINE, COVALENTLY LINKED POROUS NETWORK | UNIVERSITY OF SOUTH CAROLINA (US) | 2007-08-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160247593-A1 | CONDUCTIVE OPEN FRAMEWORKS | GJB2, OR10J3, EPCAM | NQO1 695/4885KDM4E 2184/4885MAPT 3871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.